Summary
Latest filing:
Pasha Sarraf is Director of Cue Biopharma, Inc. (CUE). 4 SEC Form 4 filings on record, most recently on 28 August 2026. Most recent open-market trade: bought $23K of CUE on 2 January 2026. Lifetime open-market purchases: $100K. Historical track record: 5/5 stars across 5 tracked purchases.
Recent Transactions
7Every recent SEC Form 4 transaction Pasha Sarraf has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Pasha Sarraf files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.61M of CUE open-market activity in the last 12 months
- Sumita Ray - $266K of CUE open-market activity in the last 12 months
- Michael Vincent Meluzio - $169K of CUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pasha Sarraf?
Pasha Sarraf is a corporate insider, tracked as Director of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pasha Sarraf submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Pasha Sarraf been buying or selling stock?
Recorded transactions: 5 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
How accurate is Pasha Sarraf's historical track record?
Across 5 tracked purchases, Pasha Sarraf averaged +19.5% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Pasha Sarraf's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pasha Sarraf and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
